Awareness about Movement Disorders among Ukrainian Neurologists
Objective: The purpose of our study was to determine the level of awareness of movement disorders (MD) among general neurologists (GN) in Ukraine. Background: Awareness…Computer Vision for Quantitative Assessment of Posture and Instability in Parkinson’s Disease
Objective: To investigate whether markerless computer vision can objectively quantify axial symptoms in Parkinson’s disease (PD), focusing on posture and instability. Background: Axial symptoms such…Inter-Rater Variability in Motor Assessment Scoring: Measurement Implications for Understanding Movement Disorders in Aging
Objective: To quantify inter-rater agreement in independent clinician scoring of video-recorded MDS-UPDRS Part III assessments, and to characterize the distribution of scoring variability at both…The Challenges for Diagnosis of Movement Disorders in Ukraine
Objective: The purpose of our study was to identify the main problems faced by general neurologists (GN) when diagnosing movement disorders (MD) in Ukraine. Background:…Non-Motor Symptoms in Hemifacial Spasm: A Cross-Sectional Study from a Brazilian Public Tertiary Center
Objective: To determine clinical characteristics of non-motor symptoms in patients with primary hemifacial spasm (HFS) at a tertiary public center in Brazil. Background: HFS is…Cholinergic Basal Forebrain Atrophy Associates with Short-Latency Afferent Inhibition and Cognitive Impairment in Parkinson’s Disease
Objective: To investigate whether cholinergic basal forebrain (cBF) atrophy mediates the relationship between short-latency afferent inhibition (SAI) and cognitive performance in PD. Background: Cognitive impairment…Late-Onset Bulbar-Predominant Neurodegeneration Associated With a Truncating AFG3L2 Variant: Expanding the Clinical Spectrum of AFG3L2-Related Disease
Objective: To describe an atypical late-onset, bulbar-predominant neurodegenerative presentation associated with a heterozygous truncating AFG3L2 variant and contextualize this phenotype within the expanding spectrum of…Evaluating the Conversion of Immediate-Release and/or Extended-Release Levodopa to IPX203 in Patients with Parkinson’s Disease
Objective: This quality improvement (QI) project was conducted to evaluate the impact of the conversion from immediate-release (IR) and/or extended-release (ER) levodopa (LD) to mucoadhesive polymer…Utility of the Short Cognitive and Neuropsychiatric Assessment Scale (ShoCo) in a Multiethnic Asian Cohort of Patients with Progressive Supranuclear Palsy
Objective: To assess the clinical utility of the Short Cognitive and Neuropsychiatric Assessment (ShoCo) scale in a multi-ethnic Malaysian cohort of patients with progressive supranuclear…Synuclein and dopamine transporter biomarkers among phenoconverters to parkinsonian disorders
Objective: To describe and assess biological congruency, defined as expected biological profile based on abnormal CSF α-synuclein Seed Amplification Assays (CSFaSynSAA) and dopamine transporter SPECT…
- « Previous Page
- 1
- …
- 147
- 148
- 149
- 150
- 151
- …
- 1942
- Next Page »